<!DOCTYPE html><html><head><title> Pacifica Code Section 26-64-S106 </title><link rel="stylesheet" href="../../assets/style.css"/></head><body>
<b><i>
                      Effective 5/8/2018</i></b>
<br>
<b>26-64-106.&nbsp;
          </b><b>Guidelines for dispensing a self-administered hormonal contraceptive.</b>
<br>
<a id="26-64-106(1)" name="26-64-106(1)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(1)</td><td style="width:99%">
A pharmacist or pharmacist intern who dispenses a self-administered hormonal contraceptive under this chapter:
<a id="26-64-106(1)(a)" name="26-64-106(1)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
shall obtain a completed self-screening risk assessment questionnaire, that has been approved by the division in collaboration with the Board of Pharmacy and the Physicians Licensing Board, from the patient before dispensing the self-administered hormonal contraceptive;</td>
</tr>
</tbody></table>
<a id="26-64-106(1)(b)" name="26-64-106(1)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
if the results of the evaluation in Subsection <a href="#26-64-106(1)(a)">(1)(a)</a> indicate that it is unsafe to dispense a self-administered hormonal contraceptive to a patient:<a id="26-64-106(1)(b)(i)" name="26-64-106(1)(b)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
may not dispense a self-administered hormonal contraceptive to the patient; and</td>
</tr>
</tbody></table>
<a id="26-64-106(1)(b)(ii)" name="26-64-106(1)(b)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
shall refer the patient to a primary care or women's health care practitioner;</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-64-106(1)(c)" name="26-64-106(1)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
may not continue to dispense a self-administered hormonal contraceptive to a patient for more than 24 months after the date of the initial prescription without evidence that the patient has consulted with a primary care or women's health care practitioner during the preceding 24 months; and</td>
</tr>
</tbody></table>
<a id="26-64-106(1)(d)" name="26-64-106(1)(d)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(d)</td><td style="width:99%">
shall provide the patient with:<a id="26-64-106(1)(d)(i)" name="26-64-106(1)(d)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
written information regarding:
<a id="26-64-106(1)(d)(i)(A)" name="26-64-106(1)(d)(i)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
the importance of seeing the patient's primary care practitioner or women's health care practitioner to obtain recommended tests and screening; and</td>
</tr>
</tbody></table>
<a id="26-64-106(1)(d)(i)(B)" name="26-64-106(1)(d)(i)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
the effectiveness and availability of long-acting reversible contraceptives as an alternative to self-administered hormonal contraceptives; and</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-64-106(1)(d)(ii)" name="26-64-106(1)(d)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
a copy of the record of the encounter with the patient that includes:
<a id="26-64-106(1)(d)(ii)(A)" name="26-64-106(1)(d)(ii)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
the patient's completed self-assessment tool; and</td>
</tr>
</tbody></table>
<a id="26-64-106(1)(d)(ii)(B)" name="26-64-106(1)(d)(ii)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
a description of the contraceptives dispensed, or the basis for not dispensing a contraceptive.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-64-106(2)" name="26-64-106(2)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(2)</td><td style="width:99%">
If a pharmacist dispenses a self-administered hormonal contraceptive to a patient, the pharmacist shall, at a minimum, provide patient counseling to the patient regarding:
<a id="26-64-106(2)(a)" name="26-64-106(2)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
the appropriate administration and storage of the self-administered hormonal contraceptive;</td>
</tr>
</tbody></table>
<a id="26-64-106(2)(b)" name="26-64-106(2)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
potential side effects and risks of the self-administered hormonal contraceptive;</td>
</tr>
</tbody></table>
<a id="26-64-106(2)(c)" name="26-64-106(2)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
the need for backup contraception;</td>
</tr>
</tbody></table>
<a id="26-64-106(2)(d)" name="26-64-106(2)(d)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(d)</td><td style="width:99%">
when to seek emergency medical attention; and</td>
</tr>
</tbody></table>
<a id="26-64-106(2)(e)" name="26-64-106(2)(e)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(e)</td><td style="width:99%">
the risk of contracting a sexually transmitted infection or disease, and ways to reduce the risk of contraction.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-64-106(3)" name="26-64-106(3)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(3)</td><td style="width:99%">
The division, in collaboration with the Board of Pharmacy and the Physicians Licensing Board, shall make rules in accordance with <a href="../../Title63G/Chapter3/63G-3.html?v=C63G-3_1800010118000101">Title 63G, Chapter 3, Utah Administrative Rulemaking Act</a>, establishing the self-screening risk assessment questionnaire described in Subsection <a href="#26-64-106(1)(a)">(1)(a)</a>.</td>
</tr>
</tbody></table>
<br>
<br>Enacted by Chapter <a href="http://le.utah.gov/UtahCode/ChapterLookup.jsp?chap=295&amp;sess=2018GS">295</a>, 2018 General Session<br>
<br>
<i>Technically renumbered for proper placement.</i>
<br>
</body></html>